You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
鍵凱科技(688356.SH):下游客户中包括部分小核酸藥物的研發企業
格隆匯 07-30 16:55

格隆匯7月30日丨鍵凱科技(688356.SH)在投資者互動平台表示,公司與康希諾生物子公司康希諾(上海)生物研發有限公司合作開發的基於新型可離子化甾醇脂質(ISL)的三組分脂質納米顆粒(ISL-3C-LNP)遞送系統在安全性提高和細胞免疫應答增強方面有顯著效果,並具有組分簡化與專利優勢,相關研究已發表在國際權威期刊ACS Applied Materials & Interfaces上。公司下游客户中包括部分小核酸藥物的研發企業,公司基於客户需求為客户提供各類常規或定製化產品。目前公司客户均處在臨牀前或早期臨牀階段,尚未對公司營業收入產生重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account